10.21.14
Marken is expanding its global cold chain network for conditioning and preparation of temperature controlled packaging solutions. The company plans to have additional qualified equipment and capacity at all of its 30 locations by the end of this year.
New GDP enforcement guidelines has generated a significant global increase in client requests for secure, just in time temperature control of Investigational Medical Product (IMP) shipments.
"Cost pressures and the challenge of managing global durable packaging solutions are driving Pharma companies to look for solid partnerships who offer a strong, reliable network for clinical trial supplies," said Dan Bell, Marken's vice president Regulatory Compliance and Technical Affairs. "The increased regulatory scrutiny and requirement for a GDP compliant supply chain is driving us to increase our capacity and manage a growing number of phase change temperature controlled solutions."
New GDP enforcement guidelines has generated a significant global increase in client requests for secure, just in time temperature control of Investigational Medical Product (IMP) shipments.
"Cost pressures and the challenge of managing global durable packaging solutions are driving Pharma companies to look for solid partnerships who offer a strong, reliable network for clinical trial supplies," said Dan Bell, Marken's vice president Regulatory Compliance and Technical Affairs. "The increased regulatory scrutiny and requirement for a GDP compliant supply chain is driving us to increase our capacity and manage a growing number of phase change temperature controlled solutions."
